A Single-Dose, Single-Center, Randomized, Five Period Crossover Study Comparing Food Effect and Bioavailability of Deflazacort Formulations in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 21 Aug 2017
At a glance
- Drugs Deflazacort (Primary)
- Indications Duchenne muscular dystrophy
- Focus Pharmacokinetics
- Sponsors Marathon Pharmaceuticals
- 12 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jul 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 02 Jul 2015 New trial record